AstraZeneca withdraws COVID-19 vaccine citing a decline in demand - dofaq.co
AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
ABC News - 08 May 2024
AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine, Vaxzevria, which is no longer being manufactured or supplied, the company said.
AstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trial
Clinical Trials Arena - 08 May 2025
AstraZeneca and Daiichi’s Enhertu shows pCR rate improvement in breast cancer trial ...
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs
The Guardian - 29 Apr 2025
Drugmaker AstraZeneca shifts more production to US amid Trump tariffs ...
Big Pharma Showdown: Novartis vs. AstraZeneca in Q1 2025 Profits and Emissions Cuts
CarbonCredits.com - 07 May 2025
Big Pharma Showdown: Novartis vs. AstraZeneca in Q1 2025 Profits and Emissions Cuts ...
Does the GSK or AstraZeneca share price currently offer the best value?
Fool UK - 08 May 2025
Does the GSK or AstraZeneca share price currently offer the best value? ...
AstraZeneca (LSE:AZN) Reports Positive Phase 3 Trial Results For Breast Cancer Treatment
Yahoo Finance - 07 May 2025
AstraZeneca (LSE:AZN) Reports Positive Phase 3 Trial Results For Breast Cancer Treatment ...
AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer
PMLiVE - 08 May 2025
AstraZeneca/Daiichi Sankyo share positive phase 3 results for Enhertu in early breast cancer ...
AstraZeneca invests €600 million in new hub in Lisbon
Portugal Resident - 08 May 2025
AstraZeneca invests €600 million in new hub in Lisbon ...
AZ's $300M cell therapy manufacturing site opens in Maryland
Fierce Pharma - 06 May 2025
AZ's $300M cell therapy manufacturing site opens in Maryland ...
AstraZeneca ‘committed’ to US manufacturing as profits rise
Financial Times - 29 Apr 2025
AstraZeneca ‘committed’ to US manufacturing as profits rise ...
AstraZeneca unveils new factory as part of multibillion-dollar investment in US manufacturing
Fox Business - 06 May 2025
AstraZeneca unveils new factory as part of multibillion-dollar investment in US manufacturing ...
[BIO KOREA 2025] AstraZeneca brings BioVentureHub model to Korea with trust-first startup partnerships
koreabiomed.com - 08 May 2025
[BIO KOREA 2025] AstraZeneca brings BioVentureHub model to Korea with trust-first startup partnerships ...
AstraZeneca quietly exits neuroscience
BioPharma Dive - 01 May 2025
AstraZeneca quietly exits neuroscience ...
AstraZeneca's Q1 2025 Financial Results
Business Wire - 29 Apr 2025
AstraZeneca's Q1 2025 Financial Results ...
AstraZeneca unit sued over alleged monopoly on blockbuster drug Soliris
Reuters - 17 Apr 2025
AstraZeneca unit sued over alleged monopoly on blockbuster drug Soliris ...
AstraZeneca, Daiichi's Enhertu extends winning streak in breast cancer trials, this time in neoadjuvant setting
FirstWord Pharma - 07 May 2025
AstraZeneca, Daiichi's Enhertu extends winning streak in breast cancer trials, this time in neoadjuvant setting ...
AstraZeneca's Calquence combo gains EC approval for lymphoma
Pharmaceutical Technology - 07 May 2025
AstraZeneca's Calquence combo gains EC approval for lymphoma ...
China, America and pay inject drama into AstraZeneca’s AGM
The Guardian - 06 Apr 2025
China, America and pay inject drama into AstraZeneca’s AGM ...
AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer trial
Fierce Pharma - 07 May 2025
AstraZeneca, Daiichi Sankyo's Enhertu rings up success in another breast cancer trial ...
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence
Reuters - 22 Apr 2025
AstraZeneca rejoins leading U.S. drug lobby group after two-year absence ...